Daniel M. Junius - 18 May 2021 Form 4 Insider Report for GLYCOMIMETICS INC (GLYC)

Reporting relationship: Director
Issuer ticker: GLYC
Reported as of: 18 May 2021
Net transaction value: $0
SEC form: 4
Accepted by SEC: 27 May 2021, 20:58:08 UTC
Prior SEC filing: 14 May 2021
Next SEC filing: 24 May 2021
Source filing: View source filing
Reporting owner signature: /s/ Brian F. Leaf, attorney-in-fact

Key filing fact

Daniel M. Junius filed Form 4 for GLYCOMIMETICS INC (GLYC) on 27 May 2021.

Key facts

This page summarizes Daniel M. Junius's Form 4 filing for GLYCOMIMETICS INC (GLYC).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 27 May 2021, 20:58.

Change

Previous filing in this sequence was filed on 14 May 2021.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

GLYC transaction

Common Stock

Award

Transaction value: $0
Shares: +5,250
Change %: +14%
Price: $0.000000
Shares after: 43,250
Date: 18 May 2021
Ownership: Direct
Footnotes: F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

GLYC transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +10,500
Change %
Price: $0.000000
Shares after: 10,500
Date: 18 May 2021
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 10,500
Exercise price: $2.55
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

The security represents restricted stock units granted to the reporting person. Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.

Footnote F2

The shares underlying these restricted stock units vest on May 18, 2022, subject to the reporting person's continuous service as of such vesting date.

Footnote F3

The shares underlying this option vest on May 18, 2022, subject to the reporting person's continuous service as of such vesting date.